Sirolimus

Islet Transplantation in Type 1 Diabetic Kidney Allograft

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations

Safety and Durability of Sirolimus for Treatment of LAM

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease

SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Resorbable Magnesium Scaffolds Registry

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Weekly Sirolimus Therapy

Methods of T Cell Depletion Trial (MoTD)

The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

Combination Therapy for the Treatment of Diffuse Midline Gliomas

COAST Therapy in Advanced Solid Tumors and Prostate Cancer

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

RAPA-201 Therapy of Solid Tumors

mTOR as Mediator of Insulin Sensitivity Study

The Role of Sirolimus in Preventing Functional Decline in Older Adults

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma

Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)

Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia

Pilot Trial for Treatment of Recurrent Glioblastoma

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

GENOSS Coronary Stent Clinical Trial

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer

Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Allo HSCT Using RIC and PTCy for Hematological Diseases

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer

Rapalog Pharmacology (RAP PAC) Study

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

Advancing Transplantation Outcomes in Children

National Registry of Rare Kidney Diseases

Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial

Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial

Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

VTP-1000 in Adults With Celiac Disease

Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

177Lu-DOTATATE for Recurrent Meningioma

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)

Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

DCB vs. DES in Bifurcation Coronary Lesions

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Efficacy and Safety of Sirolimus-Coated Spiral Balloon for Coronary Bifurcation Lesions

RESTOR: PK/PD mTORi Inhibition in Older Adults

CRUZ Tunisia-Multivessel Registry

Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations

Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

MTOR Inhibitors in Older Adults

UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation

Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A

Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions

EVR and EPO for Liver Transplant Tolerance

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Experience in Percutaneous Coronary Intervention With Sirolimus Drug-Coated Balloon and Paclitaxel Drug-Coated Balloon

Allo HSCT for High Risk Hemoglobinopathies

Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study

Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19

A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

Angiolite Registry Study

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation

An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations

Virtue® SAB in the Treatment of Coronary ISR Trial

Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma

EVERO Drug-coated Balloon (DCB) Randomized Trial

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Rapamycin-Eluting Vertebral Stents In The Real-World Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Systematic Approach for Children With Orbital Malformation With Sirolimus Use

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy

Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions

Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)

Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP

Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus Burden

First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to Treat Subjects Who Have Coronary Artery Disease (CAD) Involving In-Stent Restenosis (ISR) or an Unstented Lesion in a Small Coronary Vessel (DNSV).

Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder

Inpatient Evaluation of Adults With Schizophrenia

Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant

CCI-779 in Treating Patients With Advanced Solid Tumors

A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant

Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection

CCI-779 in Treating Patients With Prostate Cancer

Islet Transplantation for Type 1 Diabetes

CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme

CCI-779 in Treating Patients With Metastatic Melanoma

CCI-779 in Treating Patients With Malignant Glioma

Pediatric Kidney Transplant Without Calcineurin Inhibitors

Steroid Withdrawal in Pediatric Kidney Transplant Recipients

CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer

CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients

Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients

Sirolimus for Focal Segmental Glomerulosclerosis

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Sirolimus in Treating Patients With Glioblastoma Multiforme

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients

Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy

Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

Daclizumab and Sirolimus to Treat Uveitis

Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment

CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer

Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)

Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients

CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor

RAD001 in Recurrent Endometrial Cancer Patients

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate

Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor

Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy

A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors

Everolimus in Treating Patients With Stage IV Melanoma

Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)

Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)

Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)

European Trial of Immunosuppression in SPK Tx

Efficacy and Safety of Sirolimus in Combination With Tacrolimus

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

Allogenic Islet Cell Transplantation

A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression

The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus

Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets

Study Evaluating Sirolimus in Kidney Transplant Recipients.

Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids

Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.

Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant

Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries

Study Evaluating Sirolimus in Kidney Transplant Recipients

Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients

The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial

GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions

Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation

Polymorphism of the Cytochrome P450-system in Renal Transplants

Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure

Study Evaluating CCI-779 in Relapsing Multiple Sclerosis

Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI

Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.

The Study to Assess AMI Treated With Balloon Angioplasty.

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.

A Study of the SMART Stent in the Treatment SFA Disease.

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions

Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)

Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.

The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.

A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.

The Arterial Revascularization Therapies Study Part II.

Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Study Evaluating Rapamune in Patients After Kidney Transplantation

Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

Rapamycin vs Methotrexate in Diffuse SSc

CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients

Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

MGA031, Sirolimus and Tacrolimus in Islet Transplantation

RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function

The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

Study Evaluating Sirolimus in the Treatment of Kidney Transplant

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients

Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation

Sirolimus Eluting Stenting in Acute Myocardial Infarction

Treatment of Bifurcated Coronary Lesions With Cypher™-Stent

Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)

CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.

Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection

Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Clinical Islet Transplantation Using the Edmonton Protocol

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

Comparison of Sirolimus and Azathioprine in Lung Transplantation

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

The Intra-Drug Eluting Stent (DES) Restenosis Study

Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis

Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Phase II Trial of RAD001 in Refractory Colorectal Cancer

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)

Pilot Study for HLA Identical Living Donor Renal Transplant Recipients

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Influence of Genes on Sirolimus Metabolism in Patients With Kidney Transplantation

Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer

TBI Dose De-escalation for Fanconi Anemia

Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

Rapamycin With Grapefruit Juice for Advanced Malignancies

Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer

PIoglitazone for PrEvention of Restenosis in Diabetic Patients

Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Sorafenib and RAD001 Renal Cell Carcinoma

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Limus Eluted From A Durable Versus ERodable Stent Coating

Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)

Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

Sirolimus for Autoimmune Disease of Blood Cells

Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma

Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy

Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation

Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)

A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer

RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Efficacy and Safety of Sirolimus in LAM

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy

Shift to Everolimus (RAD) Kidney Sparing Study

A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma

Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients

Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Donor Stem Cell Transplantation for Congenital Immunodeficiencies

Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients

Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease

Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Islet Transplantation in Type 1 Diabetes

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

A Multi-center Post-Market Surveillance Registry

Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients

Islet Allotransplantation With Steroid Free Immunosuppression

Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer

Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer

Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis

Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma

Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient

Comparison of Stent Graft, Sirolimus Stent, and Bare Metal Stent Implanted in Patients With Acute Coronary Syndrome

A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer

The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer

Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program

Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients

Strategies to Improve Islet Survival

Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients

Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

B-Lymphocyte Immunotherapy in Islet Transplantation

Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast

PEPCAD III Substudy: Stem Cell Mobilization

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

DEBlue Stent vs Cypher Stent in the Treatment of Advanced Coronary Artery Disease

Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)

Study Evaluating Rapamune® Maintenance Regimen

A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Comparison Between Pioglitazone and SES With type2 DM

Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma

Study Investigating Rapamune For Post-Marketing Surveillance

Focal In-stent Restenosis After Drug-Eluting Stent

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent

Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions

Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety

Fibrosis in Renal Allografts

Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions

Phase I Study of Patupilone and RAD001

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus

Safe Renal Function In Long Term Heart Transplanted Patients

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Phase 1 Study With Sorafenib and Sirolimus

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors

Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

RAD001 in Advanced Hepatocellular Carcinoma

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer

Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies

Proleukin and Rapamune in Type 1 Diabetes

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer